The objectives of this core are to isolate and propagate primary human leukocytes (monocytes and peripheral blood lymphocytes and maintain a brain bank of pathological tissues [for all projects and cores]. In addition, the core will provide murine bone-marrow-derived macrophages, human and murine neuronal and glial cells for studies of neural progenitors and cell-based nanoformulations in neuroAIDS. Rigorous quality control measures are in place for this well-integrated core. Substantive uses of these facilities were provided to all investigators during the previous funding cycle. Primary human leukocytes will be fractionated into monocytes and lymphocytes from HIV-1, 2 and hepatitis B and C seronegative donors by centrifugal elutriation. Human glia (microglia and astrbcytes) and/or neurons will be obtained from fetal tissues. The neurons, glia, and/or progenitor cells from human and mouse brain tissue will be purified, characterized and provided for experiments (all projects). The Brain Bank will also be operated through this core. Two hundred and thirty-six specimens are available, which include tissues with neuropathological diagnoses of Alzheimer's disease, HIV-1-associated dementia and other neurodegenerative disorders (including but not limited to stroke, Parkinson's disease, and multiple sclerosis). Patients who died of diseases not related to the nervous system serve as age-matched controls. These primary adult human cells and other tissues from Brain Bank will be utilized within to prepare RNA and protein specimen banks. Brain tissue lysates for RNA and protein investigations and frozen and paraffin tissues for immunohistochemistry will be an available resource. These will provide data for common endpoints of disease. In toto, this 'cells and tissue core'will provide all the biological specimens necessary to address research objectives of the program project and utilize the carefully controlled specimens obtained through this infrastructure to investigate neural immunity and its links to neurodegeneration.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS043985-10
Application #
8377760
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
2014-02-28
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
10
Fiscal Year
2012
Total Cost
$135,773
Indirect Cost
$43,410
Name
University of Nebraska Medical Center
Department
Type
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Zhang, Gang; Guo, Dongwei; Dash, Prasanta K et al. (2016) The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy. Nanomedicine 12:109-22
Dong, Weiguo; Embury, Christine M; Lu, Yaman et al. (2016) The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation. J Neuroinflammation 13:184
Guo, Dongwei; Zhou, Tian; Araínga, Mariluz et al. (2016) Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine. J Acquir Immune Defic Syndr :
Araínga, Mariluz; Su, Hang; Poluektova, Larisa Y et al. (2016) HIV-1 cellular and tissue replication patterns in infected humanized mice. Sci Rep 6:23513
Olson, Katherine E; Gendelman, Howard E (2016) Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease. Curr Opin Pharmacol 26:87-95
Olson, Katherine E; Bade, Aditya N; Schutt, Charles R et al. (2016) Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease. Neurotherapeutics 13:635-46
Li, Weizhe; Tong, Hsin-I; Gorantla, Santhi et al. (2016) Neuropharmacologic Approaches to Restore the Brain's Microenvironment. J Neuroimmune Pharmacol 11:484-94
Singh, Dhirender; McMillan, JoEllyn; Hilaire, James et al. (2016) Development and characterization of a long-acting nanoformulated abacavir prodrug. Nanomedicine (Lond) 11:1913-27
Sajja, Balasrinivasa R; Bade, Aditya N; Zhou, Biyun et al. (2016) Generation and Disease Model Relevance of a Manganese Enhanced Magnetic Resonance Imaging-Based NOD/scid-IL-2Rγc(null) Mouse Brain Atlas. J Neuroimmune Pharmacol 11:133-41
Bade, Aditya N; Gorantla, Santhi; Dash, Prasanta K et al. (2016) Manganese-Enhanced Magnetic Resonance Imaging Reflects Brain Pathology During Progressive HIV-1 Infection of Humanized Mice. Mol Neurobiol 53:3286-97

Showing the most recent 10 out of 218 publications